Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-014134
Filing Date
2022-03-01
Accepted
2022-03-01 17:09:01
Documents
1
Period of Report
2022-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6837
  Complete submission text file 0001209191-22-014134.txt   8395
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACHAOGEN, INC. 7000 SHORELINE COURT, SUITE 371 SOUTH SAN FRANCISCO CA 94080
Business Address
Hillan Kenneth J. (Reporting) CIK: 0001600359 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 22699535